ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $542,000 | -0.4% | 164,200 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $544,000 | -1.8% | 164,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $554,000 | -8.3% | 164,200 | +4.2% | 0.00% | -50.0% |
| Q1 2020 | $604,000 | -77.7% | 157,600 | -64.8% | 0.01% | -71.4% |
| Q4 2019 | $2,704,000 | -20.1% | 447,600 | 0.0% | 0.03% | -22.2% |
| Q3 2019 | $3,384,000 | -30.4% | 447,600 | +24.7% | 0.04% | +200.0% |
| Q2 2019 | $4,860,000 | +400.0% | 358,800 | +100.0% | 0.01% | +100.0% |
| Q1 2019 | $972,000 | +265.4% | 179,400 | +450.3% | 0.01% | +200.0% |
| Q3 2018 | $266,000 | -16.4% | 32,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | -3.0% | 32,600 | -13.5% | 0.00% | 0.0% |
| Q1 2018 | $328,000 | +1.9% | 37,700 | -1.8% | 0.00% | 0.0% |
| Q3 2017 | $322,000 | -16.6% | 38,400 | +100.0% | 0.00% | 0.0% |
| Q1 2017 | $386,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 25,445 | $19,000 | 0.05% |
| ETF MANAGERS GROUP, LLC | 2,258,970 | $1,654,000 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 116,780 | $85,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 131,036 | $96,000 | 0.01% |
| Bernardo Wealth Planning LLC | 30,469 | $20,000 | 0.01% |
| PCG Wealth Advisors, LLC | 15,200 | $12,000 | 0.00% |
| Penserra Capital Management LLC | 212,298 | $155,000 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $36,000 | 0.00% |
| King Wealth Management Group | 16,000 | $12,000 | 0.00% |
| Vident Investment Advisory, LLC | 105,398 | $77,000 | 0.00% |